Mammoth Biosciences
mammoth.bioOperator of a biotechnology company intended to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics.
LBX PPS
1Y return
$4.25
Implied Valuation
$439.2M
-68.4% premium
Last Round
Apr 2024
$13.45
Series D · $1.4B
Activity
0.8
#125 most active
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...